When Cancer Drugs Break the Heart’s Vascular Sensor Targeted cancer therapies known as tyrosine kinase inhibitors (TKIs) have transformed cancer...
cardiovascular
Professor Allan Lawrie from Imperial College London, discusses the future of personalised cardiovascular disease detection and monitoring, including comment on...
Credit: Unsplash/CC0 Public Domain A new randomized controlled trial out of the Baker Heart and Diabetes Institute has found that...
People who survive cancer may be at heightened risk of cardiovascular disease in subsequent years, data suggests.However, heart scans may...
